267 related articles for article (PubMed ID: 21576089)
21. Systems biology-defined NF-kappaB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status.
Yan B; Chen G; Saigal K; Yang X; Jensen ST; Van Waes C; Stoeckert CJ; Chen Z
Genome Biol; 2008; 9(3):R53. PubMed ID: 18334025
[TBL] [Abstract][Full Text] [Related]
22. Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.
Das R; Coupar J; Clavijo PE; Saleh A; Cheng TF; Yang X; Chen J; Van Waes C; Chen Z
Mol Carcinog; 2019 Mar; 58(3):411-425. PubMed ID: 30488488
[TBL] [Abstract][Full Text] [Related]
23. The p53 homologue DeltaNp63alpha interacts with the nuclear factor-kappaB pathway to modulate epithelial cell growth.
King KE; Ponnamperuma RM; Allen C; Lu H; Duggal P; Chen Z; Van Waes C; Weinberg WC
Cancer Res; 2008 Jul; 68(13):5122-31. PubMed ID: 18593911
[TBL] [Abstract][Full Text] [Related]
24. Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways.
Yang X; Cheng H; Chen J; Wang R; Saleh A; Si H; Lee S; Guven-Maiorov E; Keskin O; Gursoy A; Nussinov R; Fang J; Van Waes C; Chen Z
Cancer Immunol Res; 2019 Nov; 7(11):1760-1774. PubMed ID: 31624067
[TBL] [Abstract][Full Text] [Related]
25. IL-23 promotes growth and proliferation in human squamous cell carcinoma of the oral cavity.
Fukuda M; Ehara M; Suzuki S; Ohmori Y; Sakashita H
Int J Oncol; 2010 Jun; 36(6):1355-65. PubMed ID: 20428758
[TBL] [Abstract][Full Text] [Related]
26. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation.
Adams AK; Hallenbeck GE; Casper KA; Patil YJ; Wilson KM; Kimple RJ; Lambert PF; Witte DP; Xiao W; Gillison ML; Wikenheiser-Brokamp KA; Wise-Draper TM; Wells SI
Oncogene; 2015 Feb; 34(7):868-77. PubMed ID: 24608431
[TBL] [Abstract][Full Text] [Related]
27. A novel nuclear factor-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status.
Lee TL; Yang XP; Yan B; Friedman J; Duggal P; Bagain L; Dong G; Yeh NT; Wang J; Zhou J; Elkahloun A; Van Waes C; Chen Z
Clin Cancer Res; 2007 Oct; 13(19):5680-91. PubMed ID: 17908957
[TBL] [Abstract][Full Text] [Related]
28. Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101.
Duan J; Friedman J; Nottingham L; Chen Z; Ara G; Van Waes C
Mol Cancer Ther; 2007 Jan; 6(1):37-50. PubMed ID: 17237265
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway.
Wei T; Cong X; Wang XT; Xu XJ; Min SN; Ye P; Peng X; Wu LL; Yu GY
Oncotarget; 2017 Jan; 8(4):6663-6680. PubMed ID: 28035060
[TBL] [Abstract][Full Text] [Related]
30. LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB.
Wang J; An H; Mayo MW; Baldwin AS; Yarbrough WG
Cancer Cell; 2007 Sep; 12(3):239-51. PubMed ID: 17785205
[TBL] [Abstract][Full Text] [Related]
31. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
[TBL] [Abstract][Full Text] [Related]
32. ASPP2 suppresses squamous cell carcinoma via RelA/p65-mediated repression of p63.
Tordella L; Koch S; Salter V; Pagotto A; Doondeea JB; Feller SM; Ratnayaka I; Zhong S; Goldin RD; Lozano G; McKeon FD; Tavassoli M; Fritzsche F; Huber GF; Rössle M; Moch H; Lu X
Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17969-74. PubMed ID: 24127607
[TBL] [Abstract][Full Text] [Related]
33. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.
Allen CT; Ricker JL; Chen Z; Van Waes C
Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170
[TBL] [Abstract][Full Text] [Related]
34. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
35. Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma.
Yan B; Li H; Yang X; Shao J; Jang M; Guan D; Zou S; Van Waes C; Chen Z; Zhan M
PLoS One; 2013; 8(9):e73656. PubMed ID: 24069219
[TBL] [Abstract][Full Text] [Related]
36. DeltaNp63 isoforms differentially regulate gene expression in squamous cell carcinoma: identification of Cox-2 as a novel p63 target.
Boldrup L; Coates PJ; Gu X; Nylander K
J Pathol; 2009 Aug; 218(4):428-36. PubMed ID: 19391123
[TBL] [Abstract][Full Text] [Related]
37. IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas.
Wolf JS; Chen Z; Dong G; Sunwoo JB; Bancroft CC; Capo DE; Yeh NT; Mukaida N; Van Waes C
Clin Cancer Res; 2001 Jun; 7(6):1812-20. PubMed ID: 11410524
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of transcription factor nuclear factor-kappaB by a mutant inhibitor-kappaBalpha attenuates resistance of human head and neck squamous cell carcinoma to TNF-alpha caspase-mediated cell death.
Duffey DC; Crowl-Bancroft CV; Chen Z; Ondrey FG; Nejad-Sattari M; Dong G; Van Waes C
Br J Cancer; 2000 Nov; 83(10):1367-74. PubMed ID: 11044363
[TBL] [Abstract][Full Text] [Related]
39. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
Boldrup L; Coates PJ; Gu X; Nylander K
J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-kappaB and other signal transcription factors in head and neck squamous cell carcinoma.
Yan B; Yang X; Lee TL; Friedman J; Tang J; Van Waes C; Chen Z
Genome Biol; 2007; 8(5):R78. PubMed ID: 17498291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
